Propecia is statistically the most effective drug to treat male pattern baldness

Research projects for male pattern baldness have been increasing recently and they all seem to be focusing on locating genetic triggers which initiate the world’s most common type of baldness in men. Just recently the Universities of Bonn and Dusseldorf identified a group of seven gene variants all of which are directly linked to male pattern baldness. 

Finding the genes that trigger male pattern baldness not only opens up avenues of research in order to find remedies to stop the triggers from activating but also opens up the possibility of testing to see whether you have these genes at an early age, and therefore letting you know whether you will suffer from male pattern baldness in the future.

The researchers are finding that it is not just one simple gene that causes male pattern baldness but a number of interacting genetic triggers which increase the chances of the condition appearing. The process is extremely complicated and it will be many years, (if they do manage) before scientists will be able to develop something to prevent the genetic onset of male pattern baldness in men.

The researchers also noted that this research could be used to help people who suffer from deafness. The reason being is that the majority of hearing loss is due to the fact that mammals are unable to replace hair cells that have become damaged and which are essential for good hearing.

The only hair loss medication to have an effect on male pattern baldness at the genetic level is the drug Propecia made by the pharmaceutical company Merck.  Propecia works by preventing the build up of the compound of Dihydrotestosterone which occurs in the scalp in some men. The Dihydrotestosterone compound is a perfectly normal thing for men to have however it does cause male pattern baldness which is so distressing to some men.

Propecia is statistically the most effective drug to treat male pattern baldness in the world at present and is used by over 4 million men worldwide.